Content reviewed by clinical research staff

Last reviewed: March 2026Sources: PubMed, FDA, WADA Prohibited List

Evidence graded using the PeptideScholar A-D system.

Tirzepatide

Dual GIP/GLP-1 receptor agonist39 amino acidsBrand: Mounjaro, Zepbound

AFDA Approved
90
Excellent Credibility
2 cited studies | Evidence level A

Tirzepatide is the first dual GIP and GLP-1 receptor agonist, approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Achieves unprecedented weight loss in clinical trials.

Mechanism of Action

Simultaneously activates GIP and GLP-1 receptors, enhancing insulin secretion, reducing glucagon, slowing gastric emptying, and reducing appetite. The dual agonism provides additive metabolic benefits.

Benefits

  • Up to 22.5% mean body weight loss (SURMOUNT-1)[1]
  • Superior HbA1c reduction vs semaglutide (SURPASS-2)[2]
  • Improved insulin sensitivity[2]
  • Reduced cardiovascular risk factors[2]
Not medical advice - research-reported information only

This content is for informational purposes only and does not constitute medical advice.

Tirzepatide - Dosing in Published Research

Reported routes: Subcutaneous injection
Titrated from 2.5 mg SC weekly, increasing in 2.5 mg increments every 4 weeks to 5, 10, or 15 mg weekly.

The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.

Side Effects

  • Nausea and vomiting[1]
  • Diarrhea[1]
  • Decreased appetite[1]
  • Constipation[1]
  • Injection site reactions[1]

Discuss Tirzepatide with a doctor

Tirzepatide is FDA-approved and available by prescription. Licensed telehealth providers can evaluate if it's right for you.

Start Visit at Henry Meds

Get evaluated by a board-certified clinician via Henry Meds. same-week telehealth visits.

FDA approvedBoard-certified doctorsPrescription if appropriate

PeptideScholar may receive compensation from provider referrals. This does not influence our editorial content.

Approved Treatment Routing

Tirzepatide in PeptideScholar's approved-treatment dataset

Tirzepatide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities. Brand names in the current dataset: Mounjaro, Zepbound.

Validation note: This block reflects the site's current structured treatment data and internal routing logic. It is not a substitute for checking current prescribing, labeling, payer, or local regulatory details.

Tirzepatide Next Steps

US-first money path
Treatment Hub
Tirzepatide Treatment Guide

Approved product paths, real cost friction, provider routing, and tracker next steps — all in one source-backed hub.

Open treatment hub →

Research & Evidence

Compare Tirzepatide With

References

  1. 1.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med, 2022. "Tirzepatide produced mean weight reductions of 15-22.5% at 72 weeks across dose groups vs 3.1% with placebo" [PMID: 35658024]
  2. 2.Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.. N Engl J Med, 2021. "Tirzepatide at all doses was superior to semaglutide 1 mg for HbA1c reduction and weight loss" [PMID: 34170647]

Recommended Resources

The Peptide Protocols Handbook

Evidence-based reference guide covering mechanisms, research, and clinical applications.

View on Amazon

Third-Party Peptide Testing

Independent lab analysis to verify peptide purity and authenticity.

Learn More

Links may be affiliate links. See our disclosure.

GLP-1 Support Essentials

Products to help manage side effects and optimize outcomes during treatment.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Progress Tracking Tools

Monitor weight, body composition, and nutrition to maximize results.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.